Akademiliv

Sahlgrenska akademins nyheter

University of Gothenburg Logotype
  • News
  • Notices
  • Grants
  • About Akademiliv

Sahlgrenska Academy and AstraZeneca In New Research Collaboration

19 May, 2014

AnnaRudin600
Anna Rudin will divide her work between research at the Institute of Medicine, a patient clinic in arthritis at the Sahlgrenska University Hospital, and drug development Foto Sahlgrenska akademin

Respiratory and inflammatory diseases constitute a heavy burden for both the individuals affected and for society. AstraZeneca and the Sahlgrenska Academy are now entering into a collaboration in which a guest professorship has been created to reinforce research and drug development in several globally widespread and common diseases.

Respiratory, inflammatory and autoimmune diseases are focus areas given high priority within AstraZeneca’s research. The global pharmaceuticals company is currently conducting several advanced projects in the field, and is leading development in the hunt for new, effective and safe drugs.

Respiratory and inflammatory diseases are also a focus for research carried out at the Sahlgrenska Academy. With a close collaboration between the Academy, the University of Gothenburg, the Sahlgrenska University Hospital and the Västra Götaland Region, plus a number of independent clinics, the Gothenburg region have reached a unique position, in which fundamental laboratory research is directly coupled with day-to-day patient care.

A Unique Guest Professorship
Few scientists represent this collaboration better than medical doctor and researcher into inflammation Anna Rudin. She is now to become a key player in a revolutionary form of collaboration, in which the Sahlgrenska Academy and AstraZeneca reinforce each other in the continued development of the research field, through a new guest professorship.

Anna Rudin is studying the regulatory mechanisms that lie behind allergy and rheumatoid arthritis, and has established herself as one of Sweden’s leading scientists in this field, with support from the Wallenberg Foundation, the Swedish Research Council and the Vårdal Foundation, among others.

Both parties agree that she more than enough satisfies the profile of skills requirements that AstraZeneca and the Sahlgrenska Academy laid down together for the guest professorship, which specified that the person selected should possess expertise within inflammatory diseases and laboratory research methods, carrying out clinical work.

The successful candidate, furthermore, should be a good communicator, dedicated, and interested in drug development.
Linking Research and the Clinic
Anna Rudin will divide her work between research at the Institute of Medicine, a patient clinic in arthritis at the Sahlgrenska University Hospital, and drug development at AstraZeneca.

“To put it simply, I will be giving the views of an academic specialist doctor for a number of current development projects that AstraZeneca is conducting, and I will be the link between fundamental research, drug development, and the patient. This is a unique opportunity for me, where I will have the potential to use everything I have learned through the years, and furthermore be able to learn something new,” says Anna Rudin.

Her wide-reaching network of contacts is another important factor. Anna has been a member of the Associate Professor Appointments Board at the Sahlgrenska Academy, acted as scientific secretary in the Swedish Society for Rheumatology, and been a member of the board at the Karolinska Institutet Center for Allergy Research. This has given her a unique overview of the research field, and she will be able to find the expertise that AstraZeneca needs.

Shared expectations
Maarten Kraan, Head of the Respiratory, Inflammation and Autoimmunity iMed at AstraZeneca in Mölndal sees huge potential in the collaboration:

“By combining the cutting-edge expertise at the Sahlgrenska Academy with our own in this field, we are convinced that we can accelerate the development of new medicines for this vulnerable patient group.”

The Dean of the Sahlgrenska Academy, Olle Larkö, shares these hopes:

“The set-up at the Sahlgrenska Academy has shown that it offers unique possibilities for collaboration, not only between clinic and laboratory, but also between hospital, laboratory and industry. At the Sahlgrenska Academy, we are looking forward with pleasure to further reinforcing our collaboration with AstraZeneca in a very important research field. We hope that in the long term this will contribute to a better quality of life for severely ill patients.”

Anna Rudin took up the guest professorship in May.

By: Krister Svahn

By: Monica Havström
Tagged With: AstraZeneca, The Sahlgrenska Academy

HAPPY SUMMER!

The newsletter from Akademiliv will return on Wednesday, August 21st.

Contact your institute to add your event to the calendar in the Staff Portal

  • Biomedicine: Kristian Kvint: kalender@biomedicine.gu.se
  • Core Facilities: Amelie Karlsson: amelie.karlsson.2@gu.se
  • Clinical Sciences: Katarina Olinder Eriksson: klinvet@gu.se
  • Medicine: Nina Raun; kommunikation@medicine.gu.se
  • Neuroscience and Physiology: Josefin Bergenholtz; kommunikation@neuro.gu.se
  • Odontology: Johan Thompson; info@odontologi.gu.se
  • Sahlgrenska Academy’s Office and faculty-wide calendar events Åsa Ekvall; info@sahlgrenska.gu.se
  • Health and Care Sciences: Karin Mossberg; vardvetenskap@fhs.gu.se

Information from Sahlgrenska Academy Research Support Office

[UPDATED JUNE 2024]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated on a monthly basis.
Current and previous newsletters are also available in the Staff Portal.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

More news

En personlig död (A Personal Death) – a chance to win Björn Fagerberg’s new book

27 May, 2024

NEW BOOK. During his career as a physician specializing in internal medicine, Björn Fagerberg has been involved in many end-of-life situations, …  

She is doing her residency in the US with a medical degree from Gothenburg

21 May, 2024

STUDENT. Doing a “residency” in orthopedics in the United States is an unattainable dream for many newly qualified American doctors. Now Janina Ka …  

Alba Corell reports from a high-level brain tumor meeting

20 May, 2024

COLUMN. The recent gathering of the Scandinavian Society of Neuro-oncology (SNOG) in Gothenburg has concluded. Professor Asgeir Jakola hosted and …  

From South Africa to Sweden: Collaborative Research Efforts Improving Pregnant Women’s Health

17 May, 2024

GLOBAL HEALTH. In the bustling Tygerberg University Hospital in Cape Town, a dedicated research team led by Lina Bergman, is on a mission to …  

Sara Bjursten and Anna Wenger are the recipients of the Assar Gabrielsson Prize 2024

17 May, 2024

AWARD. The Assar Gabrielsson Foundation has named Anna Wenger as the winner in the basic science research category and Sara Bjursten as the …  

A full day for PhD students focused on mental health

16 May, 2024

PHD STUDENTS. For the sixth time, PhD students at Sahlgrenska Academy were invited to PhD Day, organized by the Doctoral Student Council. The day …  

Kaj Blennow ranked highest in Sweden in neuroscience

16 May, 2024

AWARD. In this year's edition of the researcher ranking from Research.com in the field of neuroscience, Kaj Blennow is ranked 17th …  

Linda Wass is doing a postdoc at Stanford with ALF funding

14 May, 2024

ALF FUNDING. Biomedical Scientist Linda Wass has just settled in Stanford, California, where she will spend two years as a postdoc. She is the …  

Karin Nilsson wrote the Thesis of the Year at Sahlgrenska Academy in 2023

14 May, 2024

AWARD. Karin Nilsson, currently a postdoc at the Department of Internal Medicine and Clinical Nutrition, receives the faculty-wide Thesis of the …  

Some answers from the proposed members of the next Faculty Board

14 May, 2024

FACULTY ELECTIONS. The eight proposed members of the next Faculty Board hereby give some brief answers on how they want to contribute to the work …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen